These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23489550)

  • 1. Bone turnover markers in statin users: a population-based analysis from the Camargo Cohort Study.
    Hernández JL; Olmos JM; Romaña G; Martinez J; Castillo J; Yezerska I; Ramos C; González-Macías J
    Maturitas; 2013 May; 75(1):67-73. PubMed ID: 23489550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cross-sectional study of bone turnover markers in healthy premenopausal women.
    de Papp AE; Bone HG; Caulfield MP; Kagan R; Buinewicz A; Chen E; Rosenberg E; Reitz RE
    Bone; 2007 May; 40(5):1222-30. PubMed ID: 17331821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of age-related chronic immobility on markers of bone turnover.
    Chen JS; Cameron ID; Cumming RG; Lord SR; March LM; Sambrook PN; Simpson JM; Seibel MJ
    J Bone Miner Res; 2006 Feb; 21(2):324-31. PubMed ID: 16418789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference intervals for bone turnover markers and their association with incident hip fractures in older men: the Health in Men study.
    Chubb SA; Byrnes E; Manning L; Beilby JP; Ebeling PR; Vasikaran SD; Golledge J; Flicker L; Yeap BB
    J Clin Endocrinol Metab; 2015 Jan; 100(1):90-9. PubMed ID: 25322270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of bone turnover markers in healthy premenopausal women.
    Adami S; Bianchi G; Brandi ML; Giannini S; Ortolani S; DiMunno O; Frediani B; Rossini M;
    Calcif Tissue Int; 2008 May; 82(5):341-7. PubMed ID: 18470550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover.
    Delmas PD; Licata AA; Reginster JY; Crans GG; Chen P; Misurski DA; Wagman RB; Mitlak BH
    Bone; 2006 Aug; 39(2):237-43. PubMed ID: 16563890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family resemblance of bone turnover rate in mothers and daughters--the MODAM study.
    Nagy H; Chapurlat R; Sornay-Rendu E; Boutroy S; Szulc P
    Osteoporos Int; 2015 Mar; 26(3):921-30. PubMed ID: 25524020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.
    Szentpetery A; McKenna MJ; Murray BF; Ng CT; Brady JJ; Morrin M; Radovits B; Veale DJ; Fitzgerald O
    J Rheumatol; 2013 May; 40(5):653-62. PubMed ID: 23457381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of vitamin D status on the effect of statins on bone mineral density and bone turnover markers in postmenopausal women.
    Hernández JL; Olmos JM; Romaña G; Llorca J; Martínez J; Castillo J; de Juan J; Pérez-Pajares I; Ruiz S; González-Macías J
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3304-9. PubMed ID: 24878047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
    Abulhul E; McDonald K; Martos R; Phelan D; Spiers JP; Hennessy M; Baugh J; Watson C; O'Loughlin C; Ledwidge M
    Clin Ther; 2012 Jan; 34(1):91-100. PubMed ID: 22154198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic effects of conjugated equine estrogen vaginal cream on bone turnover markers in postmenopausal women.
    Luengratsameerung S; Panyakhamlerd K; Treratanachat S; Taechakraichana N
    Climacteric; 2013 Feb; 16(1):133-40. PubMed ID: 22515801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone turnover markers in Spanish adult men The Camargo Cohort Study.
    Olmos JM; Hernández JL; Martínez J; Pariente E; Llorca J; González-Macías J
    Clin Chim Acta; 2010 Oct; 411(19-20):1511-5. PubMed ID: 20594548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study.
    Martínez J; Olmos JM; Hernández JL; Pinedo G; Llorca J; Obregón E; Valero C; González-Macías J
    Clin Chim Acta; 2009 Nov; 409(1-2):70-4. PubMed ID: 19737549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy.
    Cortet B; Flipo RM; Pigny P; Duquesnoy B; Racadot A; Boersma A; Delcambre B
    Rev Rhum Engl Ed; 1997 Mar; 64(3):153-9. PubMed ID: 9090763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 3 years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis.
    Eastell R; Reid DM; Vukicevic S; Ensrud KE; LaCroix AZ; Thompson JR; Thompson DD; Cummings SR
    Bone; 2012 May; 50(5):1135-40. PubMed ID: 22348983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased markers of bone turnover in children and adolescents with type 1 diabetes.
    Madsen JOB; Herskin CW; Zerahn B; Jørgensen NR; Olsen BS; Pociot F; Johannesen J
    Pediatr Diabetes; 2020 May; 21(3):505-514. PubMed ID: 31970841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density in statin users: a population-based analysis from a Spanish cohort.
    Hernández JL; Olmos JM; Romaña G; Martinez J; Castillo J; Yezerska I; Pinedo G; González-Macías J
    J Bone Miner Metab; 2014 Mar; 32(2):184-91. PubMed ID: 23784551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised, double-blinded, placebo-controlled, trial to determine the individual response in bone turnover markers to lasofoxifene therapy.
    Rogers A; Glover SJ; Eastell R
    Bone; 2009 Dec; 45(6):1044-52. PubMed ID: 19665601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two automated assays of BTM (CTX and P1NP) and reference intervals in a Danish population.
    Jørgensen NR; Møllehave LT; Hansen YBL; Quardon N; Lylloff L; Linneberg A
    Osteoporos Int; 2017 Jul; 28(7):2103-2113. PubMed ID: 28455749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.